BioRestorative Therapies Inc (BRTX) — Cash Flow Quality Index

Latest as of September 2023: -0.25x

BioRestorative Therapies Inc (BRTX) has a Cash Flow Quality Index of -0.25x as of September 2023. Operating cash flow of $-1.18 Million is below net income of $4.77 Million, suggesting accrual-heavy earnings not yet converted to cash. Explore BRTX cash generation efficiency to assess how effectively this company generates cash.

Cash Flow Quality Index

-0.25x

Operating CF / Net Income

Operating Cash Flow

$-1.18 Million

USD

Net Income

$4.77 Million

USD

Data as of

Sep 2023

Most recent filing

Annual Cash Flow Quality Index for BioRestorative Therapies Inc (None–None)

Year-by-year earnings quality comparison for BioRestorative Therapies Inc. For live market cap and the full company financial profile, see BRTX market cap overview.

Year	Quality Index	Operating CF (USD)	Net Income	YoY Change

Cash Flow Quality Index = Operating Cash Flow / Net Income. Ratios above 1.0x indicate cash-backed earnings.